Cited by 5123D Printing in Biomedical ResearchTissue Engineering and Regenerative MedicineMicrofluidic and Capillary Electrophoresis Applications

Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling

Open access
Skardal, Aleksander, Shupe, Thomas, Atala, Anthony·2016·Drug Discovery Today

Abstract

In recent years, advances in tissue engineering and microfabrication technologies have enabled rapid growth in the areas of in vitro organoid development as well as organoid-on-a-chip platforms. These 3D model systems often are able to mimic human physiology more accurately than traditional 2D cultures and animal models. In this review, we describe the progress that has been made to generate organ-on-a-chip platforms and, more recently, more complex multi-organoid body-on-a-chip platforms and their applications. Importantly, these systems have the potential to dramatically impact biomedical applications in the areas of drug development, drug and toxicology screening, disease modeling, and the emerging area of personalized precision medicine.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.drudis.2016.07.003

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • 3D tissue models, such as in vitro tissue-engineered disease models, have shown promise for overcoming obstacles faced with 2D cultured cells and animal models.

    “3D tissue models, such as in vitro tissue-engineered disease models have shown promise for addressing the current obstacles faced with 2D in vitro cultured cells and animal models [352–356].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [29]Skardal A (2015) In situ patterned micro 3-D liver constructs for parallel toxicology testing in a fluidic device. Biofabrication 7, 031001 PMC5704969 26355538

Cited by

Sorted by citations

Authors
Skardal, A., Shupe, T., & Atala, A.
Affiliations
  • Atrium Health Wake Forest Baptist (US)
  • Wake Forest University Health Sciences (US)
Corresponding author
Skardal, Aleksander
Venue
Drug Discovery Today
Publisher
Elsevier BV
Published
2016-09
Volume
21
Issue
9
Pages
1399-1411
ISSN
1359-6446 (ISSN-L)
OpenAlex
W2500581099
Cited by
512
References
85
Citations by year
2026: 33 · 2025: 44 · 2024: 48 · 2023: 44 · 2022: 49 · 2021: 70 · 2020: 58 · 2019: 57 · 2018: 57 · 2017: 43 · 2016: 8
FWCI
3.93
Type
journal article
Language
en
Open access
Locations
  • Drug Discovery Today (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Cancer Institute (R21CA229027)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
Keywords
organoids, organ-on-a-chip, body-on-a-chip, drug screening, drug toxicity testing, disease modeling, 3D tissue models, personalized medicine, microfabrication, tissue engineering
MeSH terms
Drug Evaluation, Preclinical, Humans, Models, Biological, Organoids, Tissue Engineering

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review